Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Urogenital Neoplasms

• Neoadjuvant Immune-based Combinations in Patients Undergoing Nephrectomy for Locally Advanced ccRCC
• Ph2 Study NKT2152 With Palbociclib & Sasanlimab in Subjects With Advanced Clear Cell Renal Cell Carcinoma (ccRcc)
• VTE Prevention With Rivaroxaban in Genitourinary Cancer Patients Receiving Systemic Therapy
• Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection
• A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer)
• 177Lu-PSMA Therapy Versus 177Lu-PSMA in Combination With Ipilimumab and Nivolumab for Men With mCRPC (EVOLUTION)
• Anlotinib Combined With Platinum/Gemcitabine for First Line Treatment of Advanced Urothelial Carcinoma
• Safety and Efficacy Study of Tislelizumab in Combination With BCG in HR-NMIBC Patients (TACBIN-01)
• Individualized Treatment Strategy for Patients With Metastatic Non-clear Cell Renal Cell Carcinoma
• Phase 2 Study of Neoadjuvant Immune Checkpoint Inhibitors in Urothelial Cancer
• Anlotinib Combined With Dose-reduced Olaparib in Patients With Platinum-Sensitive Recurrent Ovarian Cancer
• Efficacy and Safety of Niraparib Combined With Bevacizumab in Platinum Refractory/Resistant Recurrent Ovarian Cancer
• A Phase II, Open Lable, Single Arm, Trial to Determine Efficacy and Safety of Lenvatinib in Combination With Pembrolizumab for Platinum- Sensitive Recurrent Ovarian Cancer
• High Resolution, 18F-PSMA PET-MRI Before Prostate Cancer HIFU or Radical Prostatectomy
• Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible Sensitivity
• P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
• Bintrafusp Alfa (M7824) and NHS-IL12 (M9241) Alone and in Combination With Stereotactic Body Radiation Therapy (SBRT) in Adults With Metastatic Non-Prostate Genitourinary Malignancies
• Trial of NanoPac Focal Therapy for Prostate Cancer
• Non-Viral TCR Gene Therapy
• Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
• Personalized Treatment of Urogenital Cancers Depends on the Microbiome
• Study With Bispecific Antibody Engaging T-cells, in Patients With Progressive Cancer Diseases With Positive PSCA Marker
• Evaluation of NanoDoce® in Participants With Urothelial Carcinoma
• Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
• Nivolumab Combined With Ipilimumab for Patients With Advanced Rare Genitourinary Tumors
• Proliposomal Intravesical Paclitaxel for Treatment of Low-Grade, Stage Ta, Non Muscle Invasive Bladder Cancer
• The Importance of Albumin Infusion Rate for Plasma Volume Expansion Following Major Abdominal Surgery
• A Study of Varlilumab and Atezolizumab in Patients With Advanced Cancer
• A Study of Varlilumab (Anti-CD27) and Sunitinib in Patients With Metastatic Clear Cell Renal Cell Carcinoma
• Procaspase Activating Compound-1 (PAC-1) in the Treatment of Advanced Malignancies - Component 1
• A Phase 1 Study Evaluating the Safety, PK, and Clinical Effects of PT-112 in Subjects With Advanced Solid Tumors
• SHTC - EUROPE-1 Synergo Hyperthermia-Chemotherapy by European Urologists' Research Operation Preserving Evolution Study I
• Sunitinib Scheduling in Metastatic Renal Cell Carcinoma (mRCC)
• Study of Insulin-like Growth Factor (IGF)-Methotrexate Conjugate in the Treatment of Advanced Tumors Expressing IGF-1R
• Phase I Study of MLN8237 and Pazopanib in Patients With Solid Tumors
• Doxorubicin With or Without Sildenafil, With Analysis of Cardiac Markers
• Glivec in Prostate Cancer Patients With Rising PSA Following Radical Prostectomy
• Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
• A Study of Ixabepilone Before Surgery for High-Risk Localized Prostate Cancer
• A Trial for Patients With Advanced/Recurrent Endometrial Cancer
• A Validation Study of MR Lymphangiography Using SPIO, a New Lymphotropic Superparamagnetic Nanoparticle Contrast
• Study of Motexafin Gadolinium for the Treatment of Renal Cell (Kidney) Cancer
• Phase 2 Study of ET-743 (Trabectedin) in Patients With Persistent or Recurrent Endometrial Carcinoma